{
    "organizations": [],
    "uuid": "4fd9fbe88dce5d8516f60effefe28f93f9c31269",
    "author": "",
    "url": "https://www.reuters.com/article/brief-valeant-says-seven-key-products-ar/brief-valeant-says-seven-key-products-are-projected-to-generate-1-bln-in-sales-in-5-years-idUSFWN1P40CT",
    "ord_in_thread": 0,
    "title": "BRIEF-Valeant Says ‍Seven Key Products Are Projected To Generate $1 Bln In Sales In 5 Years​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 12:26 PM / Updated 7 minutes ago BRIEF-Valeant Says ‍Seven Key Products Are Projected To Generate $1 Bln In Sales In 5 Years​ Reuters Staff 1 Min Read \nJan 9 (Reuters) - Valeant Pharmaceuticals International Inc : \n* VALEANT - ‍SEVEN KEY PRODUCTS ARE PROJECTED TO GENERATE $1 BILLION IN SALES IN 5 YEARS​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T14:25:00.000+02:00",
    "crawled": "2018-01-09T14:41:08.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "key",
        "product",
        "projected",
        "generate",
        "bln",
        "sale",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "valeant",
        "key",
        "product",
        "projected",
        "generate",
        "billion",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}